基因治疗用腺病毒载体
徐志利,早川尧夫
摘要(Abstract)：
腺病毒载体转基因效率高 ,不受靶细胞是否为分裂细胞所限 ;容易制得高滴度病毒载体 ;生物活性评价较简便 ;在临床基因治疗方面有了越来越多的应用。但由于较高的免疫原性 ,导致一过性表达及静脉反复使用困难
关键词(KeyWords)：
腺病毒载体;基因治疗;免疫原性;生物活性评价
基金项目(Foundation):
作者(Author):
徐志利,早川尧夫
参考文献(References)：
- 1RoweWP ,etal Isolationofacytopathogenicagentfromhumanadenoidsundergoingspontaneousdegenerationintis sueculture Proc Soc Exp Biol Med 195 3 ,84:5 70～ 5 73
- 2ShenkT ,etal Adenoviridae :Thevirusesandtheirapplica tion Virology ,RavenPress NewYork 1996 :2 149～ 2 171
- 3TrentinJJ,etal Thequestforhumancancerviruses Sci ence 196 2 ,137:835～ 849
- 4GreenM ,etal Humanadenovirustransforminggenes ColdSpringHaborConferenceoncellproliferationvirusesinnatu rallyocuringtumors NewYork 1980 :373～ 397
- 5BergelsonJM ,etal Isolationofacommonreceptorforcox sackieBvirusandadenovirus 2and 5 Science 1997,2 75 :132 0～ 132 3
- 6WickhamTJ,etal IntegrinsαV β3andαVβ3promoteadenovirusinternalizationbutnotvirusattachment Cell 1993 ,73:30 9～ 319
- 7GreberUF ,etal StepwisedismantlingofadenovirusZdur ingentryintocells Cell 1993,75 :477～ 486
- 8HehirKM ,etal Molecularcharacterizationofreplication com petentvariantsofadenovirusvectorsandgenomemodificationstopreventtheirocurrence J Virol 1996 ,70 :845 9～ 846 7
- 9AndersonK ,etal Adenovirusearlyregionlamodulationofinterferonantiviralactivity J Virol 1987,6 1:787～ 795
- 10GoodingLR ,etal The 10 ,40 0 -and 14,5 0 0 -daltonproteinsencodedbyregionE3ofAdenovirusfunctiontogethertoprotectmanybutnotallmousecelllinesagainstlysisbytumornecrosisfactor J Virol 1991,6 5 :4114～ 412 3
- 11BurgertHG ,etal TheE3/l9kproteinofadenovirustype 2bindstothedomainsofhistocompatibilityantegensrequiredforCTLrecognition EMBOJ 1987,6 :2 0 19～ 2 0 2 6
- 12GrahamFL ,etal Manipulationofadenovirusvectors MethodsinMolecularBiology ,TheHumanPress ,NewYork ,1991:10 9～ 12 8
- 13MizuguchiH ,etal Efficientconstructionofarecombinantadenovirusvectorbyanimprovedinvitroligationmethod Hum Gene Ther 1998,9:2 5 77～ 2 5 83
- 14MitterederN ,etal Evaluationoftheconcentrationandbioactivityofadenovirusvectorsforgenetherapy J Vi rol 1996 ,70 :7498～ 75 0 9
- 15LoehmullerH ,etal Emergenceofearlyregion 1-contain ingreplication competentadenovirusinstocksofreplica tion defectiveadenovirusrecombinants(deltaE1+deltaE3)duringmultiplepassagesin 2 93cells Hum GeneTher 1994,5 :1485～ 1491
- 16EissaNT ,etal EvaluationoftherespiratoryepitheliumofnormalsandindividualswithcysticfibrosisforthepresenceofadenovirusE1asequencesrelevanttotheuseofE1a aden ovirusvectersforgenetherapyfortherespiratorymanifes tationsofcysticfibrosis HumanGeneTher 1994,5 :110 5～ 1114
- 17大野典也 ,etal 基因治疗开发研究手册 NDS株式会社 ,东京 ,1999:36 4～ 36 5
- 18MarkAK ,etal Transientinmunomodulationwithanti CD40ligandantibodyandCTLA4Igenhancespersistenceandsec ondaryadenovirus mediated genetransferintomouseliver Proc Natl Acad Sci USA ,1997,94:46 86～ 2 6 91
- 19NakagawaI,etal PersistentandSecondaryadenovirus mediat edhepaticgeneexpressionusingadenovirusvectorcontainingCTLA4 IgG Hum GeneTher 1998,9:1739～ 1745
- 2 0ZhangHG ,etal ApplicationofaFasligandEncodingare combinantadenovirusvectorforprolongationoftransgeneexpression J Virol 1998,72 :2 483～ 2 490
- 2 1GoodingLR ,etal A 14,70 0MWProteinfromtheE3Re gionofadenovirusinhibitscytolysisbytumornecrosisfac tor Cell 1988,5 3 :341～ 346
- 2 2IlanY ,etat InsertionoftheadenoviralE3regionintoare combinantviralvectorpreventsantiviralhumoralandcellu larimmuneresponsesandpermitslong term geneexpres sion Proc Natl Acad Sci USA ,1997,94:2 5 87～ 2 5 92
- 2 3MizuguchiH ,etal AsimplemethodforconstructingE1andE1/E4 deletedrecombinantadenovirusvector Hum GeneTher 1999,10 :2 0 13～ 2 0 17
- 2 4ChirmuleN ,etal RoleofE4 inElicitingCD4 T cellandB cellresponsetoadenovirusvectorsdeliveredtomurineandnonhumanprimatelungs J Virol 1998,72 :6 138～ 6 145
- 2 5SchiednerG ,etal GenomicDNAtransferwithahigh ca pacityadenovirusvectorresultsinimprovedinvivogeneex pressionanddecreasedtoxicity NatureGenet 1998,18:180～ 183
- 2 6MorsyMA ,etal Anadenoviralvectordeletedforallviralcodingsequencesresultsinenhancedsafetyandextendedexpressionofaleptintransgene Proc Natl Acad Sci USA ,1998,95 :786 6～ 7871
- 2 7ReechiaA ,etal Site specificintegrationmediatedbyahy bridadenovirus/adeno associatedvirusvector Proc Natl Acad Sci USA ,1999,96 :2 6 15～ 2 6 2 0
- 28ThtJournalofGeneMedicine:Internetpublicdatabasehttp:/ /www wiley com uk/ genetherapy/clinical/index html
- 2 9谷蕙三朗 癌症基因治疗研究的最前线 实验医学 (日 ) 1999,17:2 2 5 4～ 2 2 5 9
- 30KnowlesMK ,etal Acontrolledstudyofadenoviral vector mediatedgenetransferinthenasalepitheliumofpatientswithcysticfibrosis N Engl J M 1995 ,333:82 3～ 831
- 31KiwakiK ,etal Correctionofornithinetranscarbamylasedeficiencyinadultspf(ash)miceandinOTC deficienthu manhepatocyteswithrecombinantadenovirusbearingtheCAGpromoter Hum GeneTher 1996 ,7:82 1～ 830
- 32BischoffJR ,etal Anadenovirusmutantthatreplicatesse lectivelyinp5 3 deficienthumantumorcells Science 1996 ,2 74:373～ 376
- 33藤原俊义 ,等 用 p5 3基因进行的癌症基因治疗 实验医学 (日 ) 1999,17:2 2 47～ 2 2 5 3
- 34钱谷干男 ,等 用表达胞嘧啶脱氨酶的腺病毒载体合用5 氟尿嘧啶或放疗抑制向肝脏转移的临床基因治疗研究 第 6回基因治疗研究会Workshop ,东京 ,1999:12